Thermo Fisher Deal Shows Waivers, Timing Cut Antitrust Woes

Law360, New York (February 13, 2014, 4:38 PM EST) -- Drawing scrutiny from an international band of cooperating antitrust regulators led by the Federal Trade Commission, attorneys for Thermo Fisher Scientific Inc. offered a model for obtaining multijurisdictional clearance for its $13.6 billion acquisition of Life Technologies Corp., forking over confidentiality waivers and strategically plotting out their regulatory filings.

The FTC followed the lead of the European Commission and China's Ministry of Commerce late last month after Thermo Fisher finalized the sale of a trio of its business units to the health care unit of General Electric...
To view the full article, register now.